The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Trial in progress: A phase 2 study of sotorasib as first-line treatment in patients with stage IV non–small cell lung cancer (NSCLC) whose tumors harbor a KRAS p.G12C mutation (CodeBreaK 201).
Kathryn Cecilia Arbour
Consulting or Advisory Role - Sanofi
Research Funding - Genentech (Inst); Mirati Therapeutics (Inst)
Monica Khurana
Employment - Amgen
Stock and Other Ownership Interests - Amgen
Tian Dai
Employment - Amgen
Stock and Other Ownership Interests - Amgen
Ferdinandos Skoulidis
Stock and Other Ownership Interests - BioNTech; Moderna Therapeutics
Honoraria - ESMO; McGill Universite de Montreal; RV Mais
Consulting or Advisory Role - Amgen; BeiGene; Calithera Biosciences; Intellisphere; Medscape; Navire; Tango Therapeutics
Research Funding - AIMM Therapeutics (I); Amgen (Inst); Boehringer Ingelheim (Inst); Merck (Inst); Mirati Therapeutics (Inst); Novartis (Inst); Pfizer (Inst)